GRITSTONE BIO INC. - COMMON STOCK

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

07 Nov 2023 16:30:00 By Nasdaq GlobeNewswire

Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine

11 Oct 2023 07:10:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 Oct 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Presentations from Phase 1 Studies Evaluating Next-Generation Vaccine Candidate for COVID-19 at IDWeek 2023

04 Oct 2023 16:05:21 By Nasdaq GlobeNewswire

Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million

27 Sep 2023 16:01:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 Sep 2023 16:30:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

16 Aug 2023 16:30:00 By Nasdaq GlobeNewswire

Gritstone bio and Genevant Sciences Announce Option and License Agreement

15 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates

09 Aug 2023 16:05:01 By Nasdaq GlobeNewswire

Gritstone bio Partners with Friends of Cancer Research (Friends) on the ctDNA to Monitor Treatment Response (ctMoniTR) Project

07 Aug 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17 Jul 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

13 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Publication of Interim Results from Phase 1 Study of Self-amplifying mRNA (samRNA) Vaccine Against COVID-19 in Nature Communications

08 Jun 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio to Participate in Upcoming Investor Conferences

01 Jun 2023 16:30:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 May 2023 17:00:00 By Nasdaq GlobeNewswire

Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates

11 May 2023 16:05:02 By Nasdaq GlobeNewswire

Gritstone bio to Report First Quarter 2023 Financial Results and Provide Corporate Update on May 11, 2023

03 May 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL)

17 Apr 2023 07:01:00 By Nasdaq GlobeNewswire

Gritstone bio Presents Advances in Neoantigen Prediction and Cancer Vaccine Immunogenicity at the 2023 AACR Annual Meeting

17 Apr 2023 07:00:00 By Nasdaq GlobeNewswire

Gritstone bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 Apr 2023 07:00:00 By Nasdaq GlobeNewswire